Vectors for gene delivery

Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4353201, 4353723, 536 231, 536 235, 536 2372, C12N 1563, C12N 508, C07H 2104

Patent

active

059289139

ABSTRACT:
Herpesvirus amplicon preparations comprise an origin of replication, a packaging sequence, and at least one inserted gene under control of a promoter, suitable for use as an immunogen or vaccine, in association with helper herpesvirus or DNA, wherein the associated helper virus is of restricted replication competence in a normal host cell; for example where the associated helper virus has an inactivating defect in respect of a gene essential for production of infectious new virus particles, and where the amplicon carries an inserted gene necessary for the propagation of the helper virus.

REFERENCES:
patent: 4996152 (1991-02-01), Carter et al.
patent: 5501979 (1996-03-01), Geller et al.
Nguyen et. al.. Replicatin-defective mutants of Herpes Simplex Virus (HSV) induce cellular immunity and protect against lethal HSV infection. J. Virol.. vol. 66(12):7067-7072, Nov. 18, 1992.
Efstathiou et. al.. Role of Herpes Simplex Virus type I thymidine kinase in pathogenesis. J. Gen. Virol.. vol. 70:869-879, Apr. 25, 1989.
West et al. Gene expression in adeno-associated virus vectors: The effects of chimeric mRNA structure, helper virus, and adenovirus VA1 RNA. Virol. vol. 160:38-47, Jan. 1987.
Tratschin et al. A human parvovirus. adeno-associated virus, as a eucaryotic vector: transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase. Mol. and Cell. Biol. vol. 4(10):2072-2081, Oct. 1984.
Weatherall, D.J. Scope and limitations of gene therapy. British Med. Bull. vol. 51(1):1-11, Jan. 1995.
Verma et al. Gene therpay- Promises, problems and prospects. Nature. vol. 389:239-242, Sep. 18, 1997.
Orkin et al. Report and recommendations of the panel to assess the NIH investment in research on gene therapy, Dec. 7, 1995.
Lowenstein, et al., "Simultaneous Detection of Amplicon and HS-1 Helper Encoded Proteins Reveals that Neurons and Astrocytoma Cells do Express Amplicon-Borne Transgenes in the Absence of Synthesis of Virus Immediate Early Proteins", Molecular Brain Research, 30(1):169-175 (1995).
Wu, et al., "Examination of Conditions Affecting the Efficiency of HSV-1 Amplicon Packaging", J. Virol. Methods, 52:219-229 (1995).
Lowenstien, et al., "Herpes Simplex Virus 1 (HSV-1) Helper Co-Infection Affects the Distribution of an Amplicon Encoded Protein in Glia", NeuroReport, 5(13):1625-1630 (1994).
Frenkel, et al., "Minireview the Herpes SImplex Virus Amplicon--a Versatile Defective Virus Vector", Gene Therapy, 1:S40-S46 (1994).
Craig, et al., "Use of HSV-1 Amplicon Vectors to Study RNA and Protein Targeting in Cultured Hippocampal Neurons", Gene Therapy, 1:S72 (1994).
Kaplitt, et al., "Expression of a Functional Foreign Gene in Adult Mammalian Brain Following In Vivo Transfer Via a Herpes Simplex Virus Type 1 Defective Viral Vector", Mol. Cell. Neurosciences, 2:320-330 (1991).
Kwong, et al., "The Herpes Simplex Virus Amplicon IV. Efficient of a Chimeric Chicken Ovalbumin Gene Amplified Within Defective Virus Genomes", Virology, 142:421-425 (1985).
Spaete, et al. "The Herpes Simplex Virus Amplicon Analyses of CIS-Acting Replication Functions", Proc. Natl. Acad. Sci. USA, 82:694-698 (1985).
Kwong, et al., "Herpes Simplex Virus Amplicon Effect of Size on Replicon of Constructed Defective Genomes containing Eucaryotic DNA Sequences", J. Virology, 51(3) :595-603 (1984).
Spaete, et al., "The Herpes Simplex Virus Amplicon a New Eucaryotic Defective- Virus Cloning-Amplfying Vector", Cell, 30:295-304 (1982).
Leib, et al., "Is Herpes Simplex Virus the Right Tool for the Job?", Bioassays, 15(8):547-554 (1993).
Geller, et al., "An Efficient Deletion Mutant Packaging System for Defective Herpes Simplex Virus Vectors Potential Applications to Human Gene Therapy and Neuronal Physiology", Proc. Natl. Acad. Sci., 87:8950-8954 (1990).
Glover, et al., "Expression Using a Defective Herpes Simplex virus (HSV-1) Vector System", DNA Cloning 4, Oxford University Press: New York, pp. 263-283 (1995).
Lim, et al., "Generation of High-Titer Defective HSV-1 Vectors Using an IE 2 Deletion Mutant and Quantitative Study of Expression in Cultured Cortical Cells", Biotechniques, 20(3):460-469 (1996).
Berthomme, et al., "Increased Transcomplementation Properties of Plasmid Carry HSV-1 Origin of Replication and Packaging Signals", Virology, 216(2):437-443 (1996).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Vectors for gene delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vectors for gene delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vectors for gene delivery will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-877719

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.